Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, August 25, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
LUCA AICELL Launches Drug-Free Nasal Spray to Shield Against Viruses and Allergies
Life Sciences Times
-
June 28, 2025
0
People on the Move
Oceans Healthcare Appoints Dr. David Rubin as Chief Medical Officer
Life Sciences Times
-
June 28, 2025
0
Healthcare
Mended Hearts Launches Global Foundation to Support Cardiovascular Patients Worldwide
Life Sciences Times
-
June 28, 2025
0
Legal
Kahn Swick & Foti Continues Investigation Into iRhythm Technologies Over FDA Warning and Securities Suit
Life Sciences Times
-
June 28, 2025
0
Real Estate
Vetter Breaks Ground on New $285 Million Clinical Manufacturing Site in Des Plaines
Life Sciences Times
-
June 27, 2025
0
Biotech
STEMCELL Technologies Launches Automated Tissue Dissociation System to Streamline Cell Research
Life Sciences Times
-
June 27, 2025
0
Biotech
Javelin Biotech Adds Vaccine Expert Robin Robinson to Board Amid Industry Shift Toward Human-Based Drug Models
Life Sciences Times
-
June 27, 2025
0
Legal
Hims & Hers Faces Securities Fraud Class Action After Novo Nordisk Ends Partnership Over Safety Concerns
Life Sciences Times
-
June 27, 2025
0
Venture Capital
Bone Biologics Prices $5 Million Public Offering to Support Clinical Trials and Corporate Growth
Life Sciences Times
-
June 27, 2025
0
Medtech
Wysa and RxCap Partner to Improve Medication Adherence Through Remote Monitoring Integration
Life Sciences Times
-
June 27, 2025
0
1
...
33
34
35
...
710
Page 34 of 710
Most Popular
ProVerum Raises $80 Million in Series B to Advance Commercialization of BPH Treatment
August 25, 2025
Cambrex Expands Peptide Manufacturing Capabilities at Waltham, Massachusetts Facility
August 25, 2025
Merz Therapeutics Begins Phase III Trials of XEOMIN® for Migraine Prevention
August 25, 2025
Sonoma Biotherapeutics Appoints Lisa Taylor Ash as Chief Legal Officer
August 25, 2025
Load more
Recent Comments
Recent Comments